TipRanks
Go Ultimate55% OFF

Faron Pharmaceuticals Oy (4FR) Ownership - Who Owns Faron Pharmaceuticals Oy?

Faron Pharmaceuticals Oy (4FR) Ownership Overview

  • 2.04% Insiders
  • 97.96% Public Companies and Individual Investors

The ownership structure of Faron Pharmaceuticals Oy (DE:4FR) stock is a mix of institutional, retail, and individual investors. , 2.04% is owned by Insiders, and 97.96% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Mar 30, 2026Tuomo Pätsi€200,001
Mar 24, 2026Markku Jalkanen€50,004
Mar 18, 2026Juho Jalkanen€14,328
Mar 18, 2026Yrjö E K Wichmann€5,194

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

DE:4FR top shareholders
Holder# of SharesType% HoldingValue
Markku Jalkanen2,713,442Insider1.19%1,131,505
Juho Jalkanen1,172,671Insider0.51%489,004
Tuomo Pätsi453,267Insider0.20%189,012
Vesa Karvonen176,000Insider0.08%73,392
Yrjö E K Wichmann138,132Insider0.06%57,601

FAQ

What percentage of Faron Pharmaceuticals Oy (DE:4FR) stock is held by retail investors?
According to the latest TipRanks data, approximately 97.96% of Faron Pharmaceuticals Oy (DE:4FR) stock is held by public companies and individual investors.
Who owns the most shares of Faron Pharmaceuticals Oy (DE:4FR)?
Markku Jalkanen owns the most shares of Faron Pharmaceuticals Oy (DE:4FR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.